http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105017353-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2015-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105017353-B |
| titleOfInvention | Iridoid glycosides compound and its production and use in honeysuckle |
| abstract | The invention belongs to pharmaceutical technology field, be related to from caprifoliaceae plant honeysuckle ( Lonicera japonica ) a series of new iridoid glycosides compound L oniceranan A, Loniceranan B, the Loniceranan C of separation are extracted in the bud dried, they have identical secoiridoid glycosides parent nucleus.The invention further relates to such noval chemical compound and its prepare the hypoglycemic physiologically active and its medical usage of medicine.Such compound can combine with pharmaceutically acceptable carrier and clinically acceptable formulation, the treatment for each paradiabetes is made.Preparation method of the present invention is simple, favorable reproducibility, and purity is high.The compound of acquisition has good hypoglycemic activity effect. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106117284-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106117284-B |
| priorityDate | 2015-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.